Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Dec 5;12(12):CD005582.
doi: 10.1002/14651858.CD005582.pub5.

Corticosteroids for preventing postherpetic neuralgia

Xin Jiang  1 , Yanbo Li  1 , Ning Chen  1 , Muke Zhou  1 , Li He  1
Affiliations
Review

Corticosteroids for preventing postherpetic neuralgia

Xin Jiang et al. Cochrane Database Syst Rev. .

Abstract

Background: Postherpetic neuralgia (PHN) is a common, serious, painful complication of herpes zoster. Corticosteroids have anti-inflammatory properties, and might be beneficial. This is an update of a review first published in 2008, and previously updated in 2013.

Objectives: To assess the effects (benefits and harms) of corticosteroids in preventing postherpetic neuralgia.

Search methods: We updated the searches for randomised controlled trials (RCTs) of corticosteroids for preventing postherpetic neuralgia in the Cochrane Neuromuscular Specialised Register, CENTRAL, MEDLINE, Embase, two other databases, and two trials registers (June 2022). We also reviewed the bibliographies of identified trials, contacted authors, and approached pharmaceutical companies to identify additional published or unpublished data.

Selection criteria: We included all RCTs involving corticosteroids given by oral, intramuscular, or intravenous routes for people of all ages, with herpes zoster of all degrees of severity within seven days after onset, compared with no treatment or placebo, but not with other treatments.

Data collection and analysis: Two review authors independently identified potential articles, extracted data, assessed the risk of bias of each trial, and the certainty of the evidence. Disagreement was resolved by discussion among the co-authors. We followed standard Cochrane methodology.

Main results: We identified five trials with a total of 787 participants that met our inclusion criteria. No new studies were identified for this update. All were randomised, double-blind, placebo-controlled parallel-group studies. The evidence is very uncertain about the effects of corticosteroids given orally during an acute herpes zoster infection in preventing postherpetic neuralgia six months after the onset of herpes (risk ratio (RR) 0.95, 95% confidence interval (CI) 0.45 to 1.99; 2 trials, 114 participants; very low-certainty evidence (downgraded for serious risk of bias and very serious imprecision)). The three other trials that fulfilled our inclusion criteria were not included in the meta-analysis because they did not provide separate information on the number of participants with PHN at six months. Adverse events during or within two weeks after stopping treatment were reported in all five included trials. There were no observed differences in serious (RR 1.65, 95% CI 0.51 to 5.29; 5 trials, 755 participants; very low-certainty evidence (downgraded for serious risk of bias and very serious imprecision)), or non-serious adverse events (RR 1.30, 95% CI 0.90 to 1.87; 5 trials, 755 participants; low-certainty evidence (downgraded for serious risk of bias and serious imprecision)) between the corticosteroid and placebo groups. One of these trials was at high risk of bias because of incomplete outcome data, two were at unclear risk of bias, and the other was at low risk of bias. The review was first published in 2008; no new RCTs were identified for inclusion in subsequent updates in 2010, 2013, and 2023.

Authors' conclusions: Based on the current available evidence, we are uncertain about the effects of corticosteroids given orally during an acute herpes zoster infection on preventing postherpetic neuralgia. Corticosteroids given orally or intramuscularly may result in little to no difference in the risk of adverse events in people with acute herpes zoster. Some researchers have recommended using corticosteroids to relieve the zoster-associated pain in the acute phase of the disease. If further research is designed to evaluate the efficacy of corticosteroids for herpes zoster, long-term follow-up should be included to observe their effect on the transition from acute pain to postherpetic neuralgia. Future trials should include measurements of function and quality of life, as well as updated measures of pain.

Trial registration: ClinicalTrials.gov NCT05208918.

PubMed Disclaimer

Conflict of interest statement

Xin Jiang: none known Yanbo Li: none known Ning Chen: none known Muke Zhou: none known Li He: none known

Update of

Similar articles

See all similar articles

Cited by

References

References to studies included in this review

Clemmensen 1984 {published data only}
    1. Clemmensen OJ, Andersen KE. ACTH versus prednisone and placebo in herpes zoster treatment. Clinical and Experimental Dermatology 1984;9(6):557-63. [PMID: ] - PubMed
Eaglstein 1970 {published data only}
    1. Eaglstein WH, Katz R, Brown JA. The effects of early corticosteroid therapy on the skin eruption and pain of herpes zoster. JAMA 1970;211(10):1681-3. [PMID: ] - PubMed
Esmann 1987 {published data only}
    1. Esmann V, Geil JP, Kroon S, Fogh H, Peterslund NA, Petersen CS et al. Prednisolone does not prevent post-herpetic neuralgia. Lancet 1987;2(8551):126-9. [PMID: ] - PubMed
Whitley 1996 {published data only}
    1. Whitley RJ, Weiss H, Gnann JW Jr, Tyring S, Mertz GJ, Pappas PG, et al. Acyclovir with and without prednisone for the treatment of herpes zoster: a randomized, placebo-controlled trial. Annals of Internal Medicine 1996;125(5):376-83. [PMID: ] - PubMed
Wood 1994a {published data only}
    1. Wood MJ, Johnson RW, Mckendrick MW, Taylor J, Mandal BK, Crooks J. A randomized trial of acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute herpes zoster. New England Journal of Medicine 1994;330(13):896-900. [PMID: ] - PubMed

References to studies excluded from this review

Agarwal 1991 {published data only}
    1. Agarwal S, Malhotra YK, Kalla S, Khullar R, Khare AK. Comparative efficacy of phenytoin, steroid and carbamazepine in herpes zoster and post herpetic neuralgia. Indian Journal of Dermatology, Venerology and Leprology 1991;57:279-83.
Brusco 1993 {published data only}
    1. Brusco JE, Jaimovich CB, Bacchiocchi MF. Herpes zoster, study of 96 patients: postherpetic neuralgia and corticoids [Herpes zoster, estudio de 96 pacientes: neuralgia postherpética y corticoides]. Archivos Argentinos de Dermatología 1993;43(3):175-83.
Chang 2004 {published data only}
    1. Chang JF. Corticosteroids for the treatment of postherpetic neuralgia. Chinese Journal of Practical Medicine 2004;4(9):830.
Cui 2002 {published data only}
    1. Cui SS, Cheng XH. Evaluation of the effect of corticosteroids for the prevention of PHN in the elderly people. Journal of DaLian Medical University 2002;24(2):116-7.
Cui 2017 {published data only}
    1. Cui JZ, Zhang XB, Zhu P, Zhao ZB, Geng ZS, Zhang YH, et al. Effect of repetitive intracutaneous injections with local anesthetics and steroids for acute thoracic herpes zoster and incidence of postherpetic neuralgia. Pain Medicine (Malden, Mass.) 2017;18(8):1566-72. - PubMed
Dureja 2010 {published data only}
    1. Dureja GP, Usmani H, Khan M, Tahseen M, Jamal A. Efficacy of intrathecal midazolam with or without epidural methylprednisolone for management of post-herpetic neuralgia involving lumbosacral dermatomes. Pain Physician 2010;13(3):213-21. - PubMed
Guo 2001 {published data only}
    1. Guo QJ. Corticosteroids plus combined therapy for the treatment of 57 cases with herpes zoster. ShanDong Medical Journal 2001;41(1):53.
Hao 2002 {published data only}
    1. Hao SZ. Clinical efficacy of acyclovir combined with prednisone for the treatment of 48 cases with herpes zoster in aged persons. Journal of JinZhou Medical College 2002;23(5):57.
Huang 2004 {published data only}
    1. Huang YZ. Clincial efficacy of acyclovir combined prednisone given by intravenous routes for the treatment of herpes zoster in middle-aged persons. International Medical & Heath Guidance News 2004;10(2-3):81-2.
Huang 2010 {published data only}
    1. Huang ZF, Huang YZ, Ma DX. Combined treatment of famciclovir and compound betamethasone for herpes zoster in middle-aged and aged population [泛昔洛韦联合复方倍他米松注射液治疗中老年带状疱疹疗效观察]. Guangdong Medical Journal 2010;31(13):1746-7.
Ji 2009 {published data only}
    1. Ji G, Niu J, Shi Y, Hou L, Lu Y, Xiong L. The effectiveness of repetitive paravertebral injections with local anesthetics and steroids for the prevention of postherpetic neuralgia in patients with acute herpes zoster. Anesthesia and Analgesia 2009;109(5):1651-5. - PubMed
Jiang 2005 {published data only}
    1. Jiang MB, Jiang JY, Wang SJ. Clinical efficacy of ribaviron combined with dexamethasone for the treatment of 38 cases with herpes zoster in middle-aged persons. Theory and Practice of Chinese Medicine 2005;15(2):163.
Jiang 2008 {published data only}
    1. Jiang CH. Short-term combined treatment with small dose of corticosteroids and acyclovir for herpes zoster. China Journal of Leprosy and Skin Disease 2008;4:255.
Keczkes 1980 {published data only}
    1. Keczkes K, Basheer AM. Do corticosteroids prevent post-herpetic neuralgia? British Journal of Dermatology 1980;102(5):551-5. [PMID: ] - PubMed
Li 2000 {published data only}
    1. Li YF. Clinical observation of acyclovir combined with prednisone for the treatment of herpes zoster. Journal of Zhejiang Medicine. Science 2000;22(7):441-2.
Li 2002 {published data only}
    1. Li QH, Shi X, Li B. Clinical efficacy of acyclovir combined with prednisone for the treatment of herpes zoster in middle-aged persons. Chinese Journal of Dermatovenereology 2002;16(3):2.
Liao 2005 {published data only}
    1. Liao JY, Yan ZQ, Liu GT. Acyclovir plus prednisone was applied to the treatment of senile herpes zoster. Clinical Journal of Military Surgeon 2005;33(4):413-4.
Lin 2002 {published data only}
    1. Lin LZ. A combination oral therapy with prednisone and acyclovir in treatment of 34 cases with herpes zoster. Journal of Clinical Dermatology 2002;31(1):30-1.
Lin 2005 {published data only}
    1. Lin BS. Clinical efficacy of valacyclovir combined with low dosage of prednisone for the treatment of herpes zoster in aged persons. Southern China Journal of Dermato-Venereology 2005;12(1):21-2.
Liu 2003 {published data only}
    1. Liu Y, Dun SH. Aciclovir combined with prednisone for the treatment of herpes zoster neuralgia in aged persons. Chinese Journal of Clinical Rehabilitation 2003;7(11):1727.
Liu 2005 {published data only}
    1. Liu YB. Clinical observation of acyclovir combined with prednisone for the treatment of herpes zoster neuralgia in middle-aged persons. Journal of LiaoNing College of Traditional Chinese Medicine 2005;7(3):251.
Ma 2000 {published data only}
    1. Ma WY. Clincial observation of antiviral agents combined with dexamethasone for the treatment of herpes zoster. QingHai Medical Journal 2000;30(10):44.
Ma 2002 {published data only}
    1. Ma J, Cai AH, Cao MR. Glucocorticoid alleviates postherpetic neuralgia. Journal of China Clinical Medicine 2002;9(5):578-9.
Makharita 2012 {published data only}
    1. Makharita MY, Amr YM, El-Bayoumy Y. Effect of early stellate ganglion blockade for facial pain from acute herpes zoster and incidence of postherpetic neuralgia. Pain Physician 2012;15(6):467-74. - PubMed
NCT05208918 {published data only}
    1. NCT05208918. Combined application of pulsed RF and steroids to the DRG for PHN [Effectiveness and durability of combined application of pulsed radiofrequency and a steroid to the dorsal root ganglion for postherpetic neuralgia: a randomized controlled trial]. clinicaltrials.gov/ct2/show/NCT05208918 (first received 26 January 2016).
Ni 2017 {published data only}
    1. Ni J, Wang X, Tang Y, Yang L, Zeng Y, Guo Y. Subcutaneous injection of triamcinolone and lidocaine to prevent postherpetic neuralgia. Pain Physician 2017;20(5):397-403. - PubMed
Pasqualucci 2000 {published data only}
    1. Pasqualucci A, Pasqualucci V, Galla F, De Angelis V, Marzocchi V, Colussi R, et al. Prevention of post-herpetic neuralgia: acyclovir and prednisolone versus epidural local anesthetic and methylprednisolone. Acta Anaesthesiologica Scandinavica 2000;44(8):910-8. - PubMed
Rijsdijk 2013 {published data only}
    1. Rijsdijk M, Van Wijck AJ, Meulenhoff PC, Kavelaars A, Van der Tweel I, Kalkman CJ. No beneficial effect of intrathecal methylprednisolone acetate in postherpetic neuralgia patients. European Journal of Pain (London, England) 2013;17(5):714-23. - PubMed
Shi 2008 {published data only}
    1. Shi RY, Liu FZ. Acyclovir combined with prednisone for 24 patients with herpes zoster. Chinese Coummunity Doctors 2008;12:37.
Song 2009 {published data only}
    1. Song KT. Combined treatment with interferon, acyclovir and steroid for patients with herpes zoster. Chinese Journal of Misdiagnosis 2009;9(6):1344-5.
Tang 2004 {published data only}
    1. Tang JC. Andrographolide combined with prednisone for the treatment of herpes zoster in middle-aged persons. JiLin Journal of Traditional Chinese Medicine 2004;24(6):34.
van Wijck 2006 {published data only}
    1. Wijck AJ, Opstelten W, Moons KG, Essen GA, Stolker RJ, Kalkman CJ, et al. The PINE study of epidural steroids and local anaesthetics to prevent postherpetic neuralgia: a randomised controlled trial. Lancet 2006;367(9506):219-24. [PMID: ] - PubMed
Wang 2004 {published data only}
    1. Wang HQ. Clinical observation of valaciclovir combined with prednisone for the treatment of herpes zoster in middle-aged persons. Chinese of Celiopathy 2004;4(5):344-5.
Xu 1999 {published data only}
    1. Xu YC. Clinical observation of acyclovir combined with prednisone for the treatment of herpes zoster. Journal of Clinical Dermatology 1999;28(3):181.
Yang 2000 {published data only}
    1. Yang J, Huang XY, Hou J. Control study of prednisone in prevention of senile postherpetic neuralgia. Journal of Clincial Dermatology 2000;29(2):99-100.
Yang 2002 {published data only}
    1. Yang JL, Hu YY. Clinical observation of acyclovir combined with prednisone for the treatment of herpes zoster. Practical Clinical Medicine 2002;3(6):128.
Yang 2010 {published data only}
    1. Yang XM. Acyclovir combined with prednisone for herpes zoster. Chinese Journal of Clinical Rational Drug Use 2010;3(6):31.
Yin 2004 {published data only}
    1. Ying GW, He QB, Li DQ, Yu JB. Clinical observation of low dosage of corticosteroids for the prevention of PHN in elderly people. Chinese Journal of Geriatrics 2004;23(8):579.
Yin 2005 {published data only}
    1. Yin GW, He QB, Li DQ, Yu JB. The observation of efficacy and safety of glucocorticoids for the treatment of herpes zoster. Chinese Journal of Practitioner 2005;4(3):187.
Zeng 2011 {published data only}
    1. Zeng C. Corticosteroids for the treatment of postherpetic neuralgia [糖皮质激素治疗带状疱诊对防治后遗神经痛的疗效观察]. Zhong Guo Jian Kang Yue Kan (China Health Monthly) 2011;30(5):49-50.
Zhang 2003 {published data only}
    1. Zhang JM. A clinical comprehend of Virmax combined prednisone in the treatment of 30 cases with herpes zoster in aged persons. Journal of HanDan Medical College 2003;16(2):115.
Zhang 2004 {published data only}
    1. Zhang CM, Wang FF, Zhu YM, Ren Y. Control study of prednisone in prevention of senile postherpetic neuralgia. Journal of ChengDe Medical College 2004;21(3):199-200.
Zhang 2005 {published data only}
    1. Zhang JQ. Acyclovir combined with low dosage prednisone for the treatment of 30 cases with herpes zoster. Clinical Journal of Integrated Traditional and Western Medicine 2005;5(3):44.
Zheng 2004 {published data only}
    1. Zheng HY, Han J. Clinical study of early combination treatment for patients with herpes zoster. Journal of Jingangshan Medical College 2004;11(3):66.
Zhou 2000 {published data only}
    1. Zhou XY. Famciclovir combined with prednisone for the treatment of herpes zoster in aged persons. Journal of BaiQiuEn Medical College 2000;26(6):647.
Zhou 2008 {published data only}
    1. Zhou J. Clinical effect investigation of herpes zoster with glucocorticosteroids and acyclovir in old patients. Journal of North Sichuan Medical College 2008;23(3):255-6.

References to studies awaiting assessment

Hu 2001 {published data only}
    1. Hu XY. Acyclovir combined with dexamethasone for the treatment of 45 cases with herpes zoster. World Journal of Infection 2001;1:5-6.

Additional references

Asada 2019
    1. Asada H. VZV-specific cell-mediated immunity, but not humoral immunity, correlates inversely with the incidence of herpes zoster and the severity of skin symptoms and zoster-associated pain: the SHEZ study. Vaccine 2019;37(44):6776-81. [PMID: ] - PubMed
Atkins 2004
    1. Atkins D, Best D, Briss PA, Eccles M, Falck-Ytter Y, Flottorp S, et al. Grading quality of evidence and strength of recommendations. BMJ 2004;328(7454):1490. [PMID: ] - PMC - PubMed
Chawki 2022
    1. Chawki S, Vilcu AM, Etienne C, Finet F, Blanchon T, Souty C, et al. Incidence of complications of herpes zoster in individuals on immunosuppressive therapy: a register-based population study. Journal of Infection 2022;84(4):531-6. [PMID: ] - PubMed
Choo 1997
    1. Choo PW, Galil K, Donahue JG, Walker AM, Spiegelman D, Platt R. Risk factors for postherpetic neuralgia. Archives of Internal Medicine 1997;157(11):1217-24. [PMID: ] - PubMed
De Moragas 1957
    1. De Moragas JM, Kierland RR. The outcome of patients with herpes zoster. AMA Archives of Dermatology 1957;75(2):193-6. [PMID: ] - PubMed
Donahue 1995
    1. Donahue JG, Choo PW, Manson JE, Platt R. The incidence of herpes zoster. Archives of Internal Medicine 1995;155(15):1605-9. [PMID: ] - PubMed
Dworkin 1994
    1. Dworkin RH, Portenoy RK. Proposed classification of herpes zoster pain. Lancet 1994;343(8913):1648. - PubMed
Fillet 2002
    1. Fillet AM. Prophylaxis of herpesvirus infections in immunocompetent and immunocompromised older patients. Drugs & Aging 2002;19(5):343-54. - PubMed
Gan 2013
    1. Gan EY, Tian EA, Tey HL. Management of herpes zoster and post-herpetic neuralgia. American Journal of Clinical Dermatology 2013;14(2):77-85. [PMID: ] - PubMed
Griffin 1998
    1. Griffin MJ, Chambers FA, MacSullivan R. Post herpetic neuralgia: a review. Irish Journal of Medical Science 1998;167(2):74-8. - PubMed
Harbecke 2021
    1. Harbecke R, Cohen JI, Oxman MN. Herpes zoster vaccines. Journal of Infectious Diseases 2021;224(12 Suppl 2):S429-42. [PMID: ] - PMC - PubMed
Higgins 2017
    1. Higgins JPT, Altman DG, Sterne JA, editor(s). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS, editor(s), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017), Cochrane, 2017. Available from training.cochrane.org/handbook/archive/v5.2.
Higgins 2023a
    1. Higgins JPT, Lasserson T, Thomas J, Flemyng E, Churchill R. Methodological Expectations of Cochrane Intervention Reviews (MECIR). Cochrane: London, Version August 2023. Available from community.cochrane.org/mecir-manual.
Higgins 2023b
    1. Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.4 (updated August 2023). Cochrane, 2023. Available from training.cochrane.org/handbook.
Kawai 2014
    1. Kawai K, Gebremeskel BG, Acosta CJ. Systematic review of incidence and complications of herpes zoster: towards a global perspective. BMJ Open 2014;4:e004833. [PMID: ] - PMC - PubMed
Kawai 2017
    1. Kawai K, Yawn BP. Risk factors for herpes zoster: a systematic review and meta-analysis. Mayo Clinic Proceedings 2017;92(12):1806-21. [PMID: ] - PubMed
Kim 2017
    1. Kim HJ, Ahn HS, Lee JY, Choi SS, Cheong YS, Kwon K, et al. Effects of applying nerve blocks to prevent postherpetic neuralgia in patients with acute herpes zoster: a systematic review and meta-analysis. Korean Journal of Pain 2017;30(1):3-17. [PMID: ] - PMC - PubMed
Kim 2021
    1. Kim J, Kim MK, Choi GJ, Shin HY, Kim BG, Kang H. Pharmacological and non-pharmacological strategies for preventing postherpetic neuralgia: a systematic review and network meta-analysis. Korean Journal of Pain 2021;34(4):509-33. [PMID: ] - PMC - PubMed
Kost 1996
    1. Kost RG, Straus SE. Postherpetic neuralgia - pathogenesis, treatment, and prevention. New England Journal of Medicine 1996;335(1):32-42. - PubMed
Lancaster 1995
    1. Lancaster T, Silagy C, Gray S. Primary care management of acute herpes zoster: systematic review of evidence from randomised controlled trials. British Journal of General Practice 1995;45(390):39-45. - PMC - PubMed
Le 2019
    1. Le P, Rothberg M. Herpes zoster infection. BMJ (Clinical Research Ed) 2019;364:k5095. [PMID: ] - PubMed
Lefebvre 2022
    1. Lefebvre C, Glanville J, Briscoe S, Littlewood A, Marshall C, Metzendorf M-I, et al. Chapter 4: Searching for and selecting studies. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated September 2022). Cochrane, 2022. Available from training.cochrane.org/handbook/archive/v6.3.
Levinson 1985
    1. Levinson W, Shaw JC. Treatment of herpes zoster with corticosteroids - fact or faith? Western Journal of Medicine 1985;142(1):117-8. - PMC - PubMed
Liberati 2009
    1. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Medicine 2009;6(7):e1000100. [DOI: 10.1371/journal.pmed.1000100] [PMID: ] - DOI - PMC - PubMed
Lin 2002
    1. Lin LZ. A combination oral therapy with prednisone and acyclovir in treatment of 34 cases with herpes zoster. Journal of Clinical Dermatology 2002;31(1):30-1.
Lycka 1990
    1. Lycka BA. Postherpetic neuralgia and systemic corticosteroid therapy. Efficacy and safety. International Journal of Dermatology 1990;29(7):523-7. [PMID: ] - PubMed
MacDonald 2000
    1. MacDonald BK, Cockerell OC, Sander JW, Shorvon SD. The incidence and lifetime prevalence of neurological disorders in a prospective community-based study in the UK. Brain 2000;123(Pt 4):665-76. - PubMed
Mahalingam 1993
    1. Mahalingam R, Wellish M, Lederer D, Forghani B, Cohrs R, Gilden DH. Quantitation of latent varicella-zoster virus DNA in human trigeminal ganglia by polymerase chain reaction. Journal of Virology 1993;67(4):2381-4. - PMC - PubMed
McKay 2020
    1. McKay SL, Guo A, Pergam SA, Dooling K. Herpes zoster risk in immunocompromised adults in the United States: a systematic review. Clinical Infectious Diseases 2020;71(7):e125-34. [PMID: ] - PMC - PubMed
Naldi 1990
    1. Naldi L, Zucchi A, Brevi A, Cavalierid'Oro L, Cainelli T. Corticosteroids and post-herpetic neuralgia. Lancet 1990;336(8720):947. [PMID: ] - PubMed
Patil 2022
    1. Patil A, Goldust M, Wollina U. Herpes zoster: a review of clinical manifestations and management. Viruses 2022;14(2):192. [PMID: ] - PMC - PubMed
Review Manager 2020 [Computer program]
    1. Review Manager 5 (RevMan 5). Version 5.4. Copenhagen: Cochrane, 2020.
RevMan Web 2023 [Computer program]
    1. Review Manager Web (RevMan Web). Version 6.5.1. The Cochrane Collaboration, 2023. Available at revman.cochrane.org.
Rhen 2005
    1. Rhen T, Cidlowski JA. Antiinflammatory action of glucocorticoids − new mechanisms for old drugs. New England Journal of Medicine 2005;353(16):1711-23. [PMID: ] - PubMed
Rosler 1996
    1. Rosler A, Schnorpfeil F, Fritz C. Treatment of postherpetic neuralgia. New England Journal of Medicine 1996;335(23):1769. - PubMed
Saguil 2017
    1. Saguil A, Kane S, Mercado M, Lauters R. Herpes zoster and postherpetic neuralgia: prevention and management. American Family Physician 2017;96(10):656-63. [PMID: ] - PubMed
Schmader 2018
    1. Schmader K. Herpes zoster. Annals of Internal Medicine 2018;169(3):ITC19-31. [PMID: ] - PubMed
Schünemann 2023
    1. Schünemann HJ, Higgins JPT, Vist GE, Glasziou P, Akl EA, Skoetz N, et al. Chapter 14: Completing ‘Summary of findings’ tables and grading the certainty of the evidence. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.4 (updated August 2023). Cochrane, 2023. Available from training.cochrane.org/handbook.
Shirane 2017
    1. Shirane R, Tang H, Hayashi K, Okuno Y, Iso H, Asada H, et al. Relationship between cell-mediated immunity to Varicella-Zoster virus and aging in subjects from the community-based Shozu Herpes Zoster study. Journal of Medical Virology 2017;89(2):313-7. [PMID: ] - PubMed
Skoetz 2020
    1. Skoetz N, Goldkuhle M, Dalen EC, Akl EA, Trivella M, Mustafa RA, et al. GRADE guidelines 27: how to calculate absolute effects for time-to-event outcomes in summary of findings tables and Evidence Profiles. Journal of Clinical Epidemiology 2020;118:124-31. [PMID: ] - PubMed
Smith 1978
    1. Smith FP. Pathological studies of spinal nerve ganglia in relation to intractable intercostal pain. Surgical Neurology 1978;10(1):50-3. - PubMed
Stankus 2000
    1. Stankus SJ, Dlugopolski M, Packer D. Management of herpes zoster (shingles) and postherpetic neuralgia. American Family Physician 2000;61(8):2437-44; 2447-8. - PubMed
Sun 2021
    1. Sun X, Wei Z, Lin H, Jit M, Li Z, Fu C. Incidence and disease burden of herpes zoster in the population aged ≥ 50 years in China: data from an integrated health care network. Journal of Infection 2021;82(2):253-60. [PMID: ] - PubMed
Thompson 2021
    1. Thompson RR, Kong CL, Porco TC, Kim E, Ebert CD, Acharya NR. Herpes zoster and postherpetic neuralgia: changing incidence rates from 1994 to 2018 in the United States. Clinical Infectious Diseases 2021;73(9):e3210-7. [PMID: ] - PMC - PubMed
Volmink 1996
    1. Volmink J, Lancaster T, Gray S, Silagy C. Treatments for postherpetic neuralgia − a systematic review of randomised controlled trials. Family Practice 1996;13(1):84-91. - PubMed
Wang 2004
    1. Wang HQ. Clinical observation of valaciclovir combined with prednisone for the treatment of herpes zoster in middle-aged persons. Chinese Journal of Celiopathy 2004;4(5):344-5.
Ware 1998
    1. Ware JE, Gandek B. Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) Project. Journal of Clinical Epidemiology 1998;51(11):903-12. - PubMed
Wood 1994
    1. Wood MJ. Current experience with antiviral therapy for acute herpes zoster. Annals of Neurology 1994;35(Suppl 1):S65-8. [PMID: ] - PubMed
Xu 1999
    1. Xu YC. Clinical observation of acyclovir combined with prednisone for the treatment of herpes zoster. Journal of Clinical Dermatology 1999;28(3):181.
Yamada 2023
    1. Yamada K, Mori Y, Cui R, Kubota Y, Asada H, Okuno Y, et al. Predictors of herpes zoster severity and immune responses according to pain trajectories: a community-based prospective cohort study. Journal of Dermatology 2023;50(8):1020-33. [PMID: ] - PubMed
Zhang 2005
    1. Zhang JQ. Acyclovir combined with low dosage prednisone for the treatment of 30 cases with herpes zoster. Clinical Journal of Integrated Traditional and Western Medicine 2005;5(3):44.
Zhang 2022
    1. Zhang X, Wang Z, Xian Y. Efficacy of local anaesthetic and steroid combination in prevention of post-herpetic neuralgia: a meta-analysis. Pakistan Journal of Medical Sciences 2022;38(3Part-I):757-65. [PMID: ] - PMC - PubMed

References to other published versions of this review

Chen 2010
    1. Chen N, Yang M, He L, Zhang D, Zhou M, Zhu C. Corticosteroids for preventing postherpetic neuralgia. Cochrane Database of Systematic Reviews 2010, Issue 12. Art. No: CD005582. [DOI: 10.1002/14651858.CD005582.pub3] - DOI - PubMed
Han 2013
    1. Han Y, Zhang J, Chen N, He L, Zhou M, Zhu C. Corticosteroids for preventing postherpetic neuralgia. Cochrane Database of Systematic Reviews 2013, Issue 3. Art. No: CD005582. [DOI: 10.1002/14651858.CD005582.pub4] [PMID: ] - DOI - PubMed
He 2006
    1. He L, Zhang D, Zhou M, Zhu C. Corticosteroids for preventing postherpetic neuralgia. Cochrane Database of Systematic Reviews 2006, Issue 1. Art. No: CD005582. [DOI: 10.1002/14651858.CD005582] - DOI - PubMed
He 2008
    1. He L, Zhang D, Zhou M, Zhu C. Corticosteroids for preventing postherpetic neuralgia. Cochrane Database of Systematic Reviews 2008, Issue 1. Art. No: CD005582. [DOI: 10.1002/14651858.CD005582.pub2] - DOI - PubMed

MeSH terms

Substances

Associated data

LinkOut - more resources